JP2006306813A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006306813A5 JP2006306813A5 JP2005133271A JP2005133271A JP2006306813A5 JP 2006306813 A5 JP2006306813 A5 JP 2006306813A5 JP 2005133271 A JP2005133271 A JP 2005133271A JP 2005133271 A JP2005133271 A JP 2005133271A JP 2006306813 A5 JP2006306813 A5 JP 2006306813A5
- Authority
- JP
- Japan
- Prior art keywords
- mast cell
- inhibitor according
- mast
- dgla
- cell growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003630 histaminocyte Anatomy 0.000 claims 11
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims 5
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims 5
- 230000010261 cell growth Effects 0.000 claims 4
- 230000004663 cell proliferation Effects 0.000 claims 4
- 239000003966 growth inhibitor Substances 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000005456 glyceride group Chemical group 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 claims 1
- 229930186217 Glycolipid Natural products 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 125000005457 triglyceride group Chemical group 0.000 claims 1
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005133271A JP2006306813A (ja) | 2005-04-28 | 2005-04-28 | 肥満細胞増殖抑制剤 |
| EP19183855.6A EP3581178B1 (en) | 2005-02-14 | 2006-02-10 | Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient |
| EP06713928.7A EP1852114B1 (en) | 2005-02-14 | 2006-02-10 | Composition containing dihomo-y-linolenic acid (dgla) as active ingredient |
| PCT/JP2006/302787 WO2006085687A1 (ja) | 2005-02-14 | 2006-02-10 | ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物 |
| CA2599112A CA2599112C (en) | 2005-02-14 | 2006-02-10 | Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| US11/884,199 US9006287B2 (en) | 2005-02-14 | 2006-02-10 | Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient |
| CN 200610003112 CN101019853B (zh) | 2005-02-14 | 2006-02-14 | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 |
| CN2012100164426A CN102600174A (zh) | 2005-02-14 | 2006-02-14 | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 |
| US14/644,231 US9943495B2 (en) | 2005-02-14 | 2015-03-11 | Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient |
| US15/911,806 US10342773B2 (en) | 2005-02-14 | 2018-03-05 | Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005133271A JP2006306813A (ja) | 2005-04-28 | 2005-04-28 | 肥満細胞増殖抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006306813A JP2006306813A (ja) | 2006-11-09 |
| JP2006306813A5 true JP2006306813A5 (https=) | 2008-03-27 |
Family
ID=37474110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005133271A Pending JP2006306813A (ja) | 2005-02-14 | 2005-04-28 | 肥満細胞増殖抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006306813A (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006306812A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 好酸球浸潤抑制剤 |
| WO2006085687A1 (ja) | 2005-02-14 | 2006-08-17 | Suntory Limited | ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物 |
| JP4300370B2 (ja) | 2007-03-13 | 2009-07-22 | 春三 小林 | 上皮改善剤 |
| JPWO2010119873A1 (ja) * | 2009-04-13 | 2012-10-22 | 株式会社 資生堂 | 皮下脂肪増加抑制による皮膚の弾性特性の低下の防止方法 |
| CN114585355A (zh) * | 2019-10-01 | 2022-06-03 | 三得利控股株式会社 | 借由水通道蛋白3的表达调节的肠功能改善用组合物及其应用 |
| CN120187420A (zh) | 2022-11-15 | 2025-06-20 | 株式会社日水 | 用于减轻或预防过敏性鼻炎或过敏性结膜炎的症状的组合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47777B1 (en) * | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
| IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| GB8806737D0 (en) * | 1988-03-22 | 1988-04-20 | Efamol Holdings | Therapeutic composition & method |
| JPH04244023A (ja) * | 1991-01-29 | 1992-09-01 | Idemitsu Petrochem Co Ltd | ω６系不飽和脂肪酸含有薬剤 |
| JP2002047176A (ja) * | 2000-08-04 | 2002-02-12 | Idemitsu Technofine Co Ltd | ＩｇＥ産生抑制剤 |
| JP2006306812A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 好酸球浸潤抑制剤 |
| JP5546087B2 (ja) * | 2005-02-14 | 2014-07-09 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
-
2005
- 2005-04-28 JP JP2005133271A patent/JP2006306813A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jump et al. | Omega-3 fatty acid supplementation and cardiovascular disease: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases | |
| JP2007523049A5 (https=) | ||
| WO2005079797A3 (en) | Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid | |
| NZ594395A (en) | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia | |
| NZ597193A (en) | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy | |
| NZ734905A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
| JP2006219454A5 (https=) | ||
| EP2506848A4 (en) | SUBSTANCES TO REDUCE THE IMPACT OF HARD CARDIAL EVENTS CONTAINING AN EXTRACT OF RED FERMENTED RICE AND A MULTIPLE UNSATURATED OMEGA-3 FATTY ACID OR DERIVATIVES THEREOF | |
| NZ737380A (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| IN2014DN08449A (https=) | ||
| CN105918505A (zh) | 一种富含α-亚麻酸保护心血管的调和油 | |
| JP2008540394A5 (https=) | ||
| ES2875965T3 (es) | Aceite microbiano que contiene ácido dihomo-gamma-linolénico y biomasa microbiana que contiene ácido dihomo-gamma-linolénico | |
| JP2007504269A5 (https=) | ||
| JP2010540636A5 (https=) | ||
| EP2620501A3 (en) | DGAT genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants | |
| NZ716730A (en) | Methods, compositions, and devices for supplying dietary fatty acid needs | |
| WO2011103151A3 (en) | Oil compositions of stearidonic acid | |
| HK1210417A1 (en) | Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders | |
| JP2006528233A5 (https=) | ||
| GEP20125464B (en) | Dha esters and use thereof in treatment and prevention of cardiovascular disease | |
| EP4406603A3 (en) | Medium chain triglyceride compositions for use in the treatment or prevention of glucose transporter type 1 deficiency syndrome, and/or epilepsy | |
| JP2006306813A5 (https=) | ||
| AR025320A1 (es) | Composicion liquida para mejorar el pan |